Initiating SGLT2 inhibitor therapy to improve renal outcomes for persons with diabetes eligible for an intensified glucose-lowering regimen: hypothetical intervention using parametric g-formula modeling

Initiating SGLT2 inhibitor therapy to improve renal outcomes for persons with diabetes eligible for an intensified glucose-lowering regimen: hypothetical intervention using parametric g-formula modeling

Bibliographic Details
Main Authors:	Koji Kawakami, Masato Takeuchi, Nobuya Inagaki, Masahito Ogura
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-06-01
Series:	BMJ Open Diabetes Research & Care
Online Access:	https://drc.bmj.com/content/10/3/e002636.full

Similar Items

Year‐long effects of COVID‐19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single‐center retrospective study
by: Ryo Tsukaguchi, et al.
Published: (2022-12-01)

SGLT2i: beyond the glucose-lowering effect
by: Lihua Ni, et al.
Published: (2020-06-01)

Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study—the Tromsø Study
by: Goodarz Danaei, et al.
Published: (2020-05-01)

Soymilk plant simulation to predict the formula of a new Hypothetical Product
by: Iacobi Boanerges Boanerges
Published: (2018-04-01)

SGLT2 inhibitors: a new pillar of the heart failure regimen
by: Travis DeSa, et al.
Published: (2021-12-01)

Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
by: Yoshihito Fujita, et al.
Published: (2019-11-01)

Hypothetical atopic dermatitis-myeloproliferative neoplasm (AD-MPN) syndrome
by: Toshiaki eKawakami, et al.
Published: (2015-08-01)

Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption
by: Keiko Unno, et al.
Published: (2023-03-01)

The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection
by: Emily Brown, et al.
Published: (2021-01-01)

The role of SGLT2 inhibitors beyond glucose-lowering to cardio-renal protection
by: J. Karalliedde
Published: (2021-04-01)

Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
by: Lucia Scisciola, et al.
Published: (2023-02-01)

Universal palivizumab prophylaxis for children with Down syndrome in Japan: analysis with interrupted time-series
by: Masato Takeuchi, et al.
Published: (2021-04-01)

Incidence of cognitive impairment after hypothetical interventions on depression, nighttime sleep duration, and leisure activity engagement among older Chinese adults: An application of the parametric g-formula
by: Nan Zhang, et al.
Published: (2023-02-01)

Use systems pharmacology modeling to elucidate the operating characteristics of SGLT1 and SGLT2 in renal glucose reabsorption in humans
by: Yasong eLu, et al.
Published: (2014-12-01)

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
by: Sanjay Kalra, et al.
Published: (2015-01-01)

Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells
by: Eri Mukai, et al.
Published: (2022-09-01)

Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen
by: Heemskerk, A, et al.
Published: (2017)

A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
by: Yan-Ting Lu, et al.
Published: (2018-11-01)

Exploring SGLT-2 Inhibitors: Benefits beyond the Glucose-Lowering Effect—What Is New in 2023?
by: Clipper F. Young, et al.
Published: (2023-09-01)

Regulation of the intestinal sodium/ glucose cotransporter SGLT1 in health and disease
by: Stearns, A
Published: (2009)

The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing.
by: Pia V Röder, et al.
Published: (2014-01-01)

DARATUMUMAB (DARA), CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE: A QUADRUPLET INTENSIFIED TREATMENT FOR TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TE NDMM) PATIENTS
by: EQ Crusoe, et al.
Published: (2021-10-01)

The Hypothetical Rabbit
by: Michael W. Kattan
Published: (2016-05-01)

Damping correction formula considering the period‐dependent characteristics of the design response spectra of long‐period ground motions for the hypothetical Nankai Trough earthquake: An investigation of the simplified spectra and waveform example provided by the Ministry of Land, Infrastructure, Transport and Tourism
by: Masahito Kobayashi, et al.
Published: (2020-10-01)

Effectiveness of Specific Health Check-ups in Japan for the primary prevention of obesity-related diseases: a protocol for a target trial emulation
by: Tomohiro Shinozaki, et al.
Published: (2023-07-01)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
by: Munteanu Madalina Andreea, et al.
Published: (2023-04-01)

SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control
by: Canan Ersoy
Published: (2020-01-01)

Age of eligibility to run for election in Japan: a barrier to political careers?
by: Masato Kamikubo
Published: (2019-01-01)

Relational Parametricity and Control
by: Masahito Hasegawa
Published: (2006-07-01)

Hypothetical reservoir model /
by: Muhammad Hidayatullah Azmi, 1989-, author, et al.
Published: (2012)

Fictional and Hypothetical Technology /
by: Bullard, Sharen, author 647941
Published: (2012)

In Defense of Weird Hypotheticals
by: Barbara A Spellman
Published: (2021-01-01)

Computing moral hypotheticals
by: Holmes, Dylan Alexander
Published: (2022)

Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using 111In-exendin-4 SPECT/CT imaging and the perspective of mitochondrial involvements
by: Muhammad Fauzi, et al.
Published: (2022-09-01)

A unique profile of insulin antibody titer in islet‐transplanted patients
by: Yamato Keidai, et al.
Published: (2022-11-01)

Long‐term outcome of islet transplantation on insulin‐dependent diabetes mellitus: An observational cohort study
by: Toshihiro Nakamura, et al.
Published: (2020-03-01)

Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors
by: Gianmarco Angelini, et al.
Published: (2021-08-01)

Hypothetical Art and Art Education: The Educational Role of the Method of Hypothetical Artwork Modelling
by: Jurij Selan
Published: (2018-01-01)

Hypothetical Art and Art Education: The Educational Role of the Method of Hypothetical Artwork Modelling
by: Jurij Selan
Published: (2011-06-01)

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
by: Simes BC, et al.
Published: (2019-10-01)